Lipid Nano Particles by Acuitas Therapeutics 2017/2018 presentation. These are the guys providing PFZR the LNP for their π. One of the main targets: liver cells. @Jikkyleaks @DeinertDoc @KathMLee1 @Undergroundcou1 @2Genervter @ichudov acuitastx.com /1
So that π that "would stay in the upper arm muscle" wouldn't by nature of it's carrier. ALC-0315 from Acuitas (patents.google.com - interesting read) again not really mentioning the product staying in your arm after injection, on the contrary /2
Back the the presentation: sorry ππseems to go all over the place. Also quite a question to ask as developer of this "Is mRNA-LNP uptake in non-liver cells receptor- mediated?"/3
Look! We make moar antibodies than natural infection! MOAR ABs good (in the lab maybe, but not in your body) . Also: MOAR π== MOAR ABs!!! ABs FTW!!!! Waht could go wrong being in a constant state of high AB levels? /4
Oh, not so good? ncbi.nlm.nih.gov /5
Back to that nasty unsearchable patent PDF. Once the LNP gets in the blood, it goes everywhere focussing on liver and spleen ,where did we hear that before
ok that was /6. Seems Ms @JesslovesMJK found similar in the PFZR docs: /7
How can we conclude other than that either those who choose to use those LNP for their πwere utterly stupid morons, not realizing it would end up all over the body turning all of your critical cells into spike factories or it was intentional ... /8
Loading suggestions...